Azithromycin and Myocardial Infarction

The overuse of azithromycin during COVID-19 led to several issues, including increased resistance to the medication. Initially, concerns centered around QT prolongation, but a recent retrospective study published in JACC: Advances discusses additional risks associated with azithromycin exposure, including ‘long-term subsequent MI,’ ’30-day hospital readmissions,’ and ’30-day incident heart failure among MI patients.’ Link to […]

Continue Reading

Cardiac arrest and IO

I personally believe that having a secure line, whether a peripheral IV or central line, is essential for resuscitating a patient. However, this is just my opinion. A recent article in NEJM highlighted that the drug administration route—IV versus IO—matters in terms of successful resuscitation, return of spontaneous circulation (ROSC), and favorable neurological outcomes. Link […]

Continue Reading